ERBB2 and breast carcinoma: Thus, we tested αHER2-eStcE in a mixed cell assay with primary human macrophages and immortalized human breast cancer cells, where we observed enhanced phagocytosis of HER2+ cells relative to HER2– cells (Supplementary Fig. 5).